Your browser doesn't support javascript.
loading
A robust brain network for sustained attention from adolescence to adulthood that predicts later substance use.
Weng, Yihe; Kruschwitz, Johann; Rueda-Delgado, Laura M; Ruddy, Kathy; Boyle, Rory; Franzen, Luisa; Serin, Emin; Nweze, Tochukwu; Hanson, Jamie; Smyth, Alannah; Farnan, Tom; Banaschewski, Tobias; Bokde, Arun L W; Desrivières, Sylvane; Flor, Herta; Grigis, Antoine; Garavan, Hugh; Gowland, Penny; Heinz, Andreas; Brühl, Rüdiger; Martinot, Jean-Luc; Martinot, Marie-Laure Paillère; Artiges, Eric; McGrath, Jane; Nees, Frauke; Orfanos, Dimitri Papadopoulos; Paus, Tomás; Poustka, Luise; Holz, Nathalie; Fröhner, Juliane H; Smolka, Michael N; Vaidya, Nilakshi; Schumann, Gunter; Walter, Henrik; Whelan, Robert.
Afiliação
  • Weng Y; School of Psychology and Global Brain Health Institute, Trinity College Dublin, Ireland.
  • Kruschwitz J; Department of Psychiatry and Psychotherapy CCM, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Rueda-Delgado LM; Collaborative Research Centre (SFB 940) "Volition and Cognitive Control", Technische Universität Dresden, 01069, Dresden, Germany.
  • Ruddy K; School of Psychology and Global Brain Health Institute, Trinity College Dublin, Ireland.
  • Boyle R; School of Psychology and Global Brain Health Institute, Trinity College Dublin, Ireland.
  • Franzen L; School of Psychology, Queens University Belfast, Belfast, Northern Ireland, UK.
  • Serin E; School of Psychology and Global Brain Health Institute, Trinity College Dublin, Ireland.
  • Nweze T; School of Psychology and Global Brain Health Institute, Trinity College Dublin, Ireland.
  • Hanson J; Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, Netherlands.
  • Smyth A; Department of Psychiatry and Psychotherapy CCM, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Farnan T; Charité -Universitätsmedizin Berlin, Einstein Center for Neurosciences Berlin, 10117, Berlin, Germany.
  • Banaschewski T; Bernstein Center for Computational Neuroscience, 10115, Berlin, Germany.
  • Bokde ALW; Department of Psychology, University of Utah, USA.
  • Desrivières S; Department of Psychology, University of Pittsburgh, Pittsburgh, PA, USA; Learning Research & Development Center, University of Pittsburgh, Pittsburgh, PA, USA.
  • Flor H; School of Psychology and Global Brain Health Institute, Trinity College Dublin, Ireland.
  • Grigis A; School of Psychology and Global Brain Health Institute, Trinity College Dublin, Ireland.
  • Garavan H; Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Square J5, 68159 Mannheim, Germany.
  • Gowland P; Discipline of Psychiatry, School of Medicine and Trinity College Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland.
  • Heinz A; Centre for Population Neuroscience and Precision Medicine (PONS), Institute of Psychiatry, Psychology & Neuroscience, SGDP Centre, King's College London, United Kingdom.
  • Brühl R; Institute of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Square J5, Mannheim, Germany.
  • Martinot JL; Department of Psychology, School of Social Sciences, University of Mannheim, 68131 Mannheim, Germany.
  • Martinot MP; NeuroSpin, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France.
  • Artiges E; Departments of Psychiatry and Psychology, University of Vermont, 05405 Burlington, Vermont, USA.
  • McGrath J; Sir Peter Mansfield Imaging Centre School of Physics and Astronomy, University of Nottingham, University Park, Nottingham, United Kingdom.
  • Nees F; Department of Psychiatry and Psychotherapy CCM, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Orfanos DP; Physikalisch-Technische Bundesanstalt (PTB), Braunschweig and Berlin, Germany.
  • Paus T; Institut National de la Santé et de la Recherche Médicale, INSERM U 1299 "Trajectoires développementales & psychiatrie", University Paris-Saclay, CNRS; Ecole Normale Supérieure Paris-Saclay, Centre Borelli; Gif-sur-Yvette, France.
  • Poustka L; Institut National de la Santé et de la Recherche Médicale, INSERM U 1299 "Trajectoires développementales & psychiatrie", University Paris-Saclay, CNRS; Ecole Normale Supérieure Paris-Saclay, Centre Borelli; Gif-sur-Yvette; and AP-HP. Sorbonne University, Department of Child and Adolescent Psychi
  • Holz N; Institut National de la Santé et de la Recherche Médicale, INSERM U 1299 "Trajectoires développementales & psychiatrie", University Paris-Saclay, CNRS; Ecole Normale Supérieure Paris-Saclay, Centre Borelli; Gif-sur-Yvette; and Psychiatry Department, EPS Barthélémy Durand, Etampes, France.
  • Fröhner JH; Discipline of Psychiatry, School of Medicine and Trinity College Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland.
  • Smolka MN; Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Square J5, 68159 Mannheim, Germany.
  • Vaidya N; Institute of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Square J5, Mannheim, Germany.
  • Schumann G; Institute of Medical Psychology and Medical Sociology, University Medical Center Schleswig Holstein, Kiel University, Kiel, Germany.
  • Walter H; NeuroSpin, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France.
  • Whelan R; Departments of Psychiatry and Neuroscience, Faculty of Medicine and Centre Hosptalier Universitaire Sainte-Justine, University of Montreal, Montreal, Quebec, Canada.
bioRxiv ; 2024 Jun 17.
Article em En | MEDLINE | ID: mdl-38617224
ABSTRACT
Substance use, including cigarettes and cannabis, is associated with poorer sustained attention in late adolescence and early adulthood. Previous studies were predominantly cross-sectional or under-powered and could not indicate if impairment in sustained attention was a predictor of substance-use or a marker of the inclination to engage in such behaviour. This study explored the relationship between sustained attention and substance use across a longitudinal span from ages 14 to 23 in over 1,000 participants. Behaviours and brain connectivity associated with diminished sustained attention at age 14 predicted subsequent increases in cannabis and cigarette smoking, establishing sustained attention as a robust biomarker for vulnerability to substance use. Individual differences in network strength relevant to sustained attention were preserved across developmental stages and sustained attention networks generalized to participants in an external dataset. In summary, brain networks of sustained attention are robust, consistent, and able to predict aspects of later substance use.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: BioRxiv Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Irlanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: BioRxiv Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Irlanda